BNP and NT-proBNP are now established for both guiding heart failure therapy decisions AND predicting cardiovascular outcomes — the dual role that has made them essential in modern cardiology.
Key findingBNP and NT-proBNP serve dual clinical roles: guiding heart failure drug therapy (titration endpoints) and predicting cardiovascular outcomes (mortalit
What the researchers found
BNP and NT-proBNP serve dual clinical roles: guiding heart failure drug therapy (titration endpoints) and predicting cardiovascular outcomes (mortality, hospitalization risk) — established as essential biomarkers in evidence-based cardiovascular care.
Why it matters
Relevant for natriuretic-peptides, cardiovascular.
How the study worked
review study.
What this study cannot tell us
See abstract.
How to read the evidence
strong evidence.
When this study was published
Published in 2008.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
B-type natriuretic peptide (BNP) and proBNP: role of emerging markers to guide therapy and determine prognosis in cardiovascular disorders.
American journal of therapeutics, 15(2), 150-6
Citation
Godkar, Darshan; Bachu, Kalyan; Dave, Bijal; Niranjan, Selva; Khanna, Ashok. (2008). B-type natriuretic peptide (BNP) and proBNP: role of emerging markers to guide therapy and determine prognosis in cardiovascular disorders.. American journal of therapeutics, 15(2), 150-6. https://doi.org/10.1097/MJT.0b013e31815af96f